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Adult T-cell leukemia/lymphoma (ATLL) is an aggressive malignancy caused by human T-cell lympho-
tropic virus type 1. The disease is characterized by the presence of pleomorphic lymphocytes and
cutaneous purpuric eruptions with skin, lymph node, visceral organs, central nervous system, and bone
marrow involvement. We herein present the case of a 70-year-old man diagnosed with ATLL. The patient
developed unique generalized cutaneous purpuric eruptions with systemic involvement including the
gastrointestinal tract, peripheral blood, and bone marrow. Despite advanced chemotherapeutic treat-
ment, he died about 5 months later due to a rapid progressive clinical course. Therefore, generalized
cutaneous purpuric eruptions could be a poorer prognostic factor in the aggressive subtype of acute ATLL.
Copyright © 2015, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Adult T-cell leukemia/lymphoma (ATLL) is an unusual form of post-
thymic lymphoma associated with the retrovirus human T-cell
lymphotropic virus type 1 (HTLV-1). A high rate of incidence of this
disease is mainly reported in the Kyushu region of Japan. Other
endemic areas are the Caribbean basin and Central Africa.1 The
onset age of ATLL in Japan is in the ﬁfth decade of life, whereas in
Brazil and Jamaica the onset age is in the fourth decade of life.2 It
has been suggested that ATLL occurs 20e30 years after the initial
HTLV-1 infection in endemic areas.1,2
It is well-known that ATLL cells inﬁltrate into different systemic
organs such as the gastrointestinal (GI) tract, liver, central nervous
system (CNS), lymph nodes, peripheral blood, bone marrow, and
skin.3,4 Leukemic inﬁltration of different organs determines clinical
presentations and morbidity.5 The most common skin manifesta-
tions reported in different case series are patch, papules, plaque, or
nodulotumoral lesions. Erythroderma or purpuric lesions could
occur as rare cutaneous presentations in some cases.6gy, Tzu-Chi General Hospital,
Taiwan, ROC. Tel.: +886 3
g).
cal Association. Published by ElsevWe herein report a rare case of ATLL presenting as generalized
purpuric skin manifestations and discuss the clinical signiﬁcance
for the prognosis of ATLL.Case report
A 70-year-old man with a medical history of chronic hepatitis B
virus without any regular medication presented to our outpatient
clinic with generalized purpuric skin eruptions for 1 week. The skin
examination revealed generalized palpable purpura with conﬂu-
ence over the scalp, trunk, and four limbs (Figure 1A and B). These
skin lesions were asymptomatic. He denied drug allergy or taking
any new medication in the recent months. One month ago, he had
epigastric pain and tarry stool. In addition, he also experienced
other systemic symptoms (general weakness, weight loss, and
arthralgia). Panendoscopy was performed, which revealed multiple
gastric ulcers. Pathologic ﬁndings of the gastric ulcer revealed
inﬁltration of atypical lymphocytes. Histopathologic examination
of the purpuric skin over the back showed massive inﬁltration of
pleomorphic atypical lymphocytes from the dermis to the
epidermis (Figure 2A). There was extravasation of erythrocytes in
the dermis and epidermis without apparent ﬁndings of vasculitis.
Inﬁltration of neoplastic atypical lymphocytes was seen in the
upper dermis with Pautrier microabscess (Figure 2B). Immuno-
histochemical studies of the abnormal lymphoid cells conﬁrmed T-ier Taiwan LLC. All rights reserved.
Figure 1 (A) Generalized asymptomatic palpable purpura with conﬂuence over the scalp, anterior trunk, (B) posterior back, and four limbs.
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CD20 and CD30 (Figure 2C and D).
Morphology of abnormal lymphoid cells in the peripheral blood
smear showed abundant polylobulated “ﬂower” cells (Figure 3A
and B). The stomach biopsy specimen was examined, whichFigure 2 (A) Massive inﬁltration of pleomorphic atypical lymphocytes from the upper der
extravasation of erythrocytes into the dermis and the epidermis, and epidermotropism of
Immunohistochemical staining showed positive results for CD3 and negative ﬁndings for CD
positive CD3 atypical T lymphocytes with Pautrier microabscess (400).revealed dense inﬁltration of the mucosa by atypical lymphocytes
(Figure 4). The presence of HTLV-1 in patient's serum was
conﬁrmed by both enzyme-linked immunosorbent assay and
Western blotting. Laboratory data revealed thrombocytopenia
(platelet count, 73,000/mL), mild anemia (hemoglobin, 11.1 g/dL),mis to epidermis (hematoxylin and eosin, 40). (B) High-power magniﬁcation shows
atypical lymphocytes with Pautrier microabscess (hematoxylin and eosin, 400). (C)
20 and CD30, which conﬁrms the T-cell linage of lymphocytes (CD3, 100). (D) Strongly
Figure 3 (A) Morphology of abnormal lymphoid cells in the peripheral blood smears showed abundant polylobulated “ﬂower” cells (Wright stain, 400). (B) High-power view of
abnormal lymphoid cells (Wright stain, 1000). (C) Pathology of bone marrow biopsy revealed diffuse atypical lymphoid cells in the bone marrow space (hematoxylin and eosin,
40). (D) Atypical pleomorphic lymphoid cells in the bone marrow space (hematoxylin and eosin, 400).
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lymphocytes; however, the prothrombin time, activated
partial thromboplastin time, and cryoglobulin were within normal
limits. In addition, laboratory ﬁndings revealed other abnormalities
including elevation of liver enzymes, alanine transaminase/aspar-
tate transaminase (198/220 IU/L; normal range < 40 IU/L), marked
elevations of lactate dehydrogenase (LDH; 1708 IU/L; normalFigure 4 (A) Examination of the stomach biopsy specimen revealed dense inﬁltration of t
matoxylin and eosin, 400). (C) Atypical lymphocytes are strongly positive for leukocyte
terminal deoxynucleotidyl transferase.range, 91e180 IU/L) and C-reactive protein (CRP; 9.7 mg/dL; normal
range < 0.8), hypoalbuminemia (3.2 g/dL; normal range,
3.8e5.3 g/dL), and hypercalcemia (10.8 mg/dL; normal range,
8.4e10.2 mg/dL).
Radiologic imaging, bone marrow imaging, and cerebrospinal
ﬂuid aspiration were arranged for staging. Fluorodeoxyglucose-
positron emission tomography imaging showed massive lymphhe mucosa (hematoxylin and eosin, 10). (B) Atypical pleomorphic lymphocytes (he-
common antigen (LCA) and CD3 but negative for CD20, CD34, cytokeratin (CK), and
Table 1 Previous reports of adult T-cell lymphoma/leukemia with speciﬁc purpuric
lesions.
Study Sex Age ATLL form
Present case M 70 Acute
Oliveira et al 201117 M 87 Acute
Okada et al 20074 F 62 Acute
Tabata et al 20073 M 76 Smoldering
Shimauchi et al 200513 F 78 Acute
Slumauclu et al 2004* M 78 Unknown
Adachi et al 2003* M 62 Acute
Adachi et al 2003* M 74 Smoldering
Masada et al 1999* F 53 Smoldering
Katalura et al 1992* M 34 Acute
Fukatani et al 1989* M 55 Smoldering
ATLL ¼ adult T-cell leukemia/lymphoma.
* References from Okada et al 2007.4
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inguinal regions, and in the right shoulder joint, as well as
increased ﬂuorodeoxyglucose uptake over the bilateral lobes of the
liver and the CNS. Bone marrow smear showed atypical prolifera-
tion of lymphoid cells and positive staining for CD45, CD1, and CD3,
and negative staining for CD20, CD30, and cytokeratin
(Figure 3C and D). Flow cytometric analysis of bone marrow aspi-
ration for blasts showed 3.7% mature T lymphocytes, 3.5% B lym-
phocytes, and 2.7% natural killer cells with normal antigenic
expression. Flow cytometric analysis of peripheral blood revealed
10.9% identical aberrant intermediate- to large-sized T cells, which
were positive for CD2, CD3, CD4, CD7, and CD8, and negative for
CD5 and CD56. Cerebrospinal ﬂuid, cytologic ﬁndings, and
cell block studies also revealed T-cell lymphoma with CNS
involvement.
Based on the clinical manifestations and laboratory, imaging,
and histopathological, and immunohistochemical studies, we
diagnosed an aggressive subtype of acute ATLL (leukemic form) by
the Shimoyama classiﬁcation. We staged the tumor according to
the Ann Arbor Staging Classiﬁcation as T-cell lymphoma/leukemia
stage IV with cutaneous, stomach, bone marrow, and CNS
involvement. The patient was treated with serial chemotherapy
regimens (cisplatin, etoposide, cytarabine, cyclophosphamide,
vincristine, doxorubicin, gemcitabine, and methotrexate). He
continued to receive these chemotherapy regimens for 4 months,
but the response was poor. His condition deteriorated and he died
5 months after the initial presentation.
Discussion
ATLL is a rare and aggressive T-cell lymphoma associated with
HTLV-1. HTLV-1 is also known to cause some vasculitides (uveitis
and retinal vasculitis) and some chronic progressive diseases such
as HTLV-1-associated myelopathy and HTLV-1-associated bron-
chopneumopathy.3 These viruses could be transmitted by breast
feeding, blood transfusion, sharing of needles, or sexual inter-
course.7 Approximately 2e5% of patients infected with the virus
will develop ATLL. The incubation time from the HTLV-1 infection
to the onset of ATLL has been estimated to be at least 20 years or
more. It occurs in adults in the 20e80-year age group (average age,
58 years). The male-to-female ratio is 1.5:1.8 The diagnosis of ATLL
is based on HTLV-1 seropositivity and histologically and/or cyto-
logically proven peripheral T-cell malignancy, as described in the
World Health Organization classiﬁcation.9 Although the mecha-
nism of malignant transformation is still unclear, the p40tax viral
protein leads to transcriptional activation of many genes in HTLV-1-
infected lymphocytes. In addition, the HTLV-1 basic leucine zipper
factor plays an important role in T-cell proliferation and
oncogenesis.10,11
According to the Shimoyama classiﬁcation, there are four clin-
ical subtypes of ATLL, including smoldering, chronic, lymphoma,
and acute. The smoldering type has the best prognosis, followed by
the chronic, lymphomatous, and acute types. The median survival
times of the acute, lymphoma, and chronic types were reported to
be 6.2 months, 10.2 months, and 24.3 months, respectively.12 Death
is caused by infectious complications. Our patient with elevated
CRP level raised the possibility of concomitant infection, which also
heralded a poor prognosis in this patient. The acute type of ATLL is
characterized by massive lymph nodes, hepatosplenomegaly, lytic
bone lesions, and multiple visceral lesions with skin, GI tract, and
lung inﬁltration. Other important ﬁndings associated with the
acute type of ATLL are hypercalcemia, elevated LDH levels, leuko-
cytosis, and eosinophilia. Clinical subtypes, age, performance sta-
tus, and serum calcium and LDH levels are the major prognostic
factors for ATLL.In fact, the skin is the most common extralymphatic site of
involvement in 50% (43e72%) patients with ATLL.6 The skin-
inﬁltrating abnormal lymphoid cells are useful to investigate tu-
mor cell biology in order to diagnose ATLL and predict a patient's
prognosis. Primary cutaneous ATLL without systemic involvement
has better clinical behavior and prognosis compared with second-
ary cutaneous ATLL. The majority of skin lesions are due to direct
invasion of ATLL tumor cells, which may cause various types of
eruptions.12 The most common cutaneous lesions in ATLL patients
are maculopapular eruptions or nodulotumoral lesions.5,6 The rare
cutaneous presentations could be erythroderma or purpuric le-
sions. The erythrodermic type had the poorest prognosis among all
skin eruptions. Most patients with erythrodermic eruptions
belonged to the acute type.
A secondary cutaneous ATLL with generalized purpuric lesions
is an uncommon skin manifestation. The prognosis for the
purpuric-type skin lesion is still unknown owing to its rarity. The
production of granzyme B by ATLL cells may lead to the destruction
of vessels and the development of purpuric eruptions in these pa-
tients.13 Purpura could be the result of thrombocytopenia or
dysfunction of platelets due to ATLL with bone marrow involve-
ment without abnormal lymphocytes inﬁltration in the skin. His-
tologically, small vessels in the upper dermis are inﬁltrated by
tumor cells (ATL cells), which may have caused tumor thrombosis
without ﬁndings of vasculitis. Therefore, the mechanism of purpura
formation in ATL is a matter of conjecture. To the best of our
knowledge, only 11 cases of diffuse purpuric lesions resulting from
ATLL cell inﬁltration have been reported to date. Ten of these cases
occurred in Japan, and one case occurred in Brazil.6 ATLL with
speciﬁc purpuric lesions wound be more predominant in the acute
clinical subtype (Table 1). According to Table 1, four of the 11 pa-
tients with localized purpuric changes had the smoldering subtype.
Six of the 11 patients with generalized purpuric changeswere in the
acute stage. Therefore, generalized cutaneous eruptions with pur-
pura could be a poorer prognostic factor in the aggressive subtype
of acute ATLL.
Although Japan is one of the most important foci of HTLV-1
infection, it is not clear why neighboring regions such as East
China or Korea have a low prevalence.14 In Taiwan, slightly more
data are available and the prevalence of HTLV-1 infection seems
higher. HTLV-1 screening revealed the seropositivity rate of 0.058%.
Furthermore, in the Taiwanese adult population aged > 30 years,
the HTLV-1 prevalence varies from 0.82% to 1.63%.15 ATLL in Taiwan
is a rare malignant T-cell lymphomawith a very poor prognosis.16,18
It is important for the dermatologists and physicians to be aware of
ATLL in day-to-day practice. In summary, we reported a patient
with primary gastric ATLL and secondary cutaneous ATLL. Acute-
type ATLL with unusual generalized cutaneous purpura associated
D.-E. Kao et al. / Dermatologica Sinica 33 (2015) 234e238238with GI, CNS, and lymph node involvement had a poor prognosis
despite aggressive chemotherapy. Hypercalcemia and elevated LDH
and CRP levels could have also been poor prognostic factors in our
case. Diffuse purpuric lesions could be the ﬁrst skin manifestation
of ATLL, and increased attention is needed in this regard.Funding/support
No funding was received for this study.References
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